Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Anticancer Research|March 10, 2015
MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in oesophageal cancerShozo Ide, Yuji Toiyama, Tadanobu Shimura, et al.
Surgery Today|May 6, 2021
Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancerYoshinaga Okugawa, Yuji Toiyama, Hiroyuki Fujikawa, et al.
Oncology Reports|August 31, 2016
Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancerYoshinaga Okugawa, Yasuhiko Mohri, Koji Tanaka, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 11, 2020
Clinical significance of advanced lung cancer inflammation index, a nutritional and inflammation index, in gastric cancer patients after surgical resection: A propensity score matching analysisChengzeng Yin, Yuji Toiyama, Yoshinaga Okugawa, et al.
Oncology Letters|June 20, 2022
Prognostic significance of CD8+ tumor-infiltrating lymphocytes and CD66b+ tumor-associated neutrophils in the invasive margins of stages I-III colorectal cancerChengzeng Yin, Yoshinaga Okugawa, Akira Yamamoto, et al.
Annals of Gastroenterological Surgery|September 4, 2024
Inflammatory Burden Index as a promising new marker for predicting surgical and oncological outcomes in colorectal cancerShinji Yamashita, Yoshinaga Okugawa, Naru Mizuno, et al.
Oncology|December 24, 2023
Clinical Significance of the Preoperative Inflammatory Burden Index in Esophageal CancerChengzeng Yin, Yoshinaga Okugawa, Takahito Kitajima, et al.
Annals of Gastroenterological Surgery|January 5, 2026
Impact of Low Preoperative Prognostic Immune Nutritional Index on Survival and Postoperative Infectious Complications in Patients With Colorectal CancerShinji Yamashita, Yoshinaga Okugawa, Hiroki Imaoka, et al.
Anticancer Research|May 31, 2015
Preoperative prediction of peritoneal metastasis in gastric cancer as an indicator for neoadjuvant treatmentMasaki Ohi, Koichiro Mori, Yuji Toiyama, et al.
Molecular and Clinical Oncology|December 4, 2014
Clinical implications of Fas/Fas ligand expression in patients with esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapySusumu Saigusa, Koji Tanaka, Masaki Ohi, et al.
Pageof 16